Search results
Bank of America Predicts up to ~200% Surge for These 2 ‘Strong Buy’ Stocks
TipRanks via Yahoo Finance· 2 days agoNew indicators of a cooling economy eased inflation concerns, driving the S&P 500 to record highs...
More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved...
WTRF Wheeling· 9 hours agoData from this study – the first Phase 3 treat-through data reported for an IL23p19 antibody – will be presented at Digestive Disease Week® (DDW), held in Washington, D.C.
What to know about the COVID-19 FLiRT variant as it spreads in Connecticut ahead of summer
The News-Times· 7 days agoThe most recent data for Connecticut, from late April, indicates that KP.2 accounts for 24 percent...
ZYMFENTRA™ (infliximab-dyyb) demonstrated long-term efficacy and safety profile of maintenance...
The Pendulum· 17 hours agoCelltrion USA announced today positive two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) for ZYMFENTRA™ (infliximab-dyyb) in adult patients with moderately to severely ...
Earnings call: Inhibikase Therapeutics reports on drug trials progress
Investing.com· 4 days agoInhibikase Therapeutics, a biopharmaceutical company focused on developing treatments for...
US FDA approves Amgen drug for small cell lung cancer
Reuters via AOL· 5 days agoThe U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's...
Novo Holdings buys stake in life sciences tools company; BioMarin lays off 170
BioPharma Dive via Yahoo Finance· 6 days agoThe parent of Novo Nordisk is acquiring 60% ownership of Single Use Support, which specializes in...
Transcriptomic signature, bioactivity and safety of a non-hepatotoxic analgesic generating AM404 in...
Nature· 7 days agoPurity of the products was determined by chromatographic analysis using an Agilent 1200 with diode array detector and Agilent 1100 MSD-Q mass detector (Column C18 Luna, 100 mm × 4< ...
Earnings call: OncoCyte outlines strategy amid Q1 revenue decline By Investing.com
Investing.com· 5 days agoOncoCyte (NASDAQ:OCX) Corporation (NYSEAMERICAN: OCX), a diagnostic testing firm, recently held its...
Earnings call: OncoCyte outlines strategy amid Q1 revenue decline
Investing.com· 6 days agoOncoCyte (NASDAQ: OCX ) Corporation (NYSEAMERICAN: OCX), a diagnostic testing firm, recently held...